Thirty-nine eligible patients were randomized to receive nebulized 9-mg sodium hyaluronate nasal washes plus saline solution ( 21 patients ) or 5 mL of saline alone ( 18 patients ) , according to an open-label , parallel-group design , with blind observer assessment .